Last $6.86 USD
Change Today -0.03 / -0.44%
Volume 12.9K
MGCD On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

mgc diagnostics corp (MGCD) Snapshot

Open
$6.89
Previous Close
$6.89
Day High
$7.11
Day Low
$6.75
52 Week High
02/19/14 - $12.34
52 Week Low
12/29/14 - $5.51
Market Cap
29.2M
Average Volume 10 Days
7.1K
EPS TTM
$-0.21
Shares Outstanding
4.3M
EX-Date
04/10/13
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MGC DIAGNOSTICS CORP (MGCD)

Related News

No related news articles were found.

mgc diagnostics corp (MGCD) Related Businessweek News

No Related Businessweek News Found

mgc diagnostics corp (MGCD) Details

MGC Diagnostics Corporation designs and markets non-invasive cardiorespiratory diagnostic products under the MGC Diagnostics and MedGraphics brand and trade names in the United States and internationally. It primarily offers pulmonary function products that include Spirometry, Complete Pulmonary Function Ultima PF, and Body Plethysmography product categories, which enable the early detection of lung disease; evaluating the effect of medication; monitoring patients with chronic disease; diagnosing lung diseases, such as asthma, emphysema, and bronchitis/chronic obstructive pulmonary disease; managing treatment; assessing the surgical risk of lung transplant and lung reduction candidates; and evaluating the impact of diseases, such as neuromuscular disease on breathing. The company also provides cardiopulmonary exercise testing products that measure functional capacity, fitness, or conditioning levels; and evaluate prognostic criteria for surgical procedures, as well as help physicians diagnose heart and lung diseases. In addition, it offers cycle ergometers and treadmills for use in diagnostic, rehabilitation, and sports medicine applications; and electronic medical records interfaces, such as BreezeConnect HL7 interface technology software, installation, and support for communications interfaces. MGC Diagnostics Corporation sells its products through a direct sales force and distributors to hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations. The company was formerly known as Angeion Corporation and changed its name to MGC Diagnostics Corporation in August 2012. MGC Diagnostics Corporation was founded in 1986 and is headquartered in Saint Paul, Minnesota.

mgc diagnostics corp (MGCD) Top Compensated Officers

Chief Financial Officer and Chief Operating O...
Total Annual Compensation: $157.9K
Compensation as of Fiscal Year 2013.

mgc diagnostics corp (MGCD) Key Developments

MGC Diagnostics Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended October 31, 2014; Provides Earnings Guidance for the Fiscal Year 2015

MGC Diagnostics Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended October 31, 2014. For the quarter, the company reported revenues of USD 9,704,000 compared to USD 9,141,000 for the same period a year ago. Operating loss was USD 51,000 compared to operating income of USD 875,000 for the same period a year ago. Loss before taxes was USD 513,000 compared to income before taxes of USD 875,000 for the same period a year ago. Net loss was USD 276,000 or USD 0.07 per basic and diluted share compared to net income of USD 836,000 or USD 0.20 per basic and diluted share for the same period a year ago. For the quarter, capitalized software development cost was USD 190,000 compared to USD 150,000 in the prior year period. For the full year, the company reported revenues of USD 30,032,000 compared to USD 31,640,000 for the same period a year ago. Operating loss was USD 767,000 compared to operating income of USD 1,426,000 for the same period a year ago. Loss before taxes was USD 1,291,000 compared to income before taxes of USD 1,427,000 for the same period a year ago. Net loss was USD 1,100,000 or USD 0.26 per basic and diluted share compared to net income of USD 1,357,000 or USD 0.34 per basic and diluted share for the same period a year ago. Net cash provided by operating activities was USD 328,000 compared to USD 2,496,000 for the same period a year ago. Purchases of property and equipment and intangible assets were USD 1,226,000 compared to USD 1,055,000 for the same period a year ago. The company will continue to realign its expense infrastructure to match its revenue. Coming into fiscal 2015, the company examined expense levels and made cuts to align expenses with projected revenue growth and profitability targets. The company will remain vigilant on this front.

MGC Diagnostics Corporation Appoints Terrence W. Bunge to its Board of Directors

MGC Diagnostics announced that Terrence W. Bunge was elected to the company’s Board of Directors, increasing the board’s size to six members. Since 2010, Bunge has managed a private investment portfolio of global companies focused on medical devices, software and biotech organizations. Prior to that, he was president, chief operating officer and director of ACIST Medical Systems Inc. While leading ACIST, he grew sales over fivefold during his seven years of leadership, achieving profitability within the first 18 months of his tenure. Other experience includes senior leadership positions with Science, Incorporated, Angeion Corporation, and Medtronic.

MGC Diagnostics Corporation to Report Q4, 2014 Results on Jan 07, 2015

MGC Diagnostics Corporation announced that they will report Q4, 2014 results at 4:30 PM, US Eastern Standard Time on Jan 07, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MGCD:US $6.86 USD -0.03

MGCD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MGCD.
View Industry Companies
 

Industry Analysis

MGCD

Industry Average

Valuation MGCD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MGC DIAGNOSTICS CORP, please visit www.mgcdiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.